Showing results (31-40 of 77) with videos related to

Sort By:
Pageof 8
Journal of Applied Clinical Medical Physics|July 18, 2018
Independent validation of machine performance check for the Halcyon and TrueBeam linacs for daily quality assuranceYuting Li, Tucker Netherton, Paige L Nitsch, et al.
Journal of Applied Clinical Medical Physics|March 4, 2018
Normal tissue doses from MV image-guided radiation therapy (IGRT) using orthogonal MV and MV-CBCTYuting Li, Tucker Netherton, Paige L Nitsch, et al.
The Journal of Nervous and Mental Disease|December 1, 1984
Cross-national reliability study of a schedule for assessing personality disordersP Tyrer, D V Cicchetti, P R Casey, et al.
Advances in Radiation Oncology|November 9, 2017
Dosimetric and clinical outcomes after volumetric modulated arc therapy for carcinoma of the thoracic esophagusCai Xu, Mian Xi, Ritsuko Komaki, et al.
Journal of Applied Clinical Medical Physics|February 19, 2025
IROC phantoms accurately detect MLC delivery errorsSharbacha S Edward, Julianne M Pollard-Larkin, Peter A Balter, et al.
Journal of Applied Clinical Medical Physics|September 26, 2019
Acceptance and verification of the Halcyon-Eclipse linear accelerator-treatment planning system without 3D water scanning systemSong Gao, Tucker Netherton, Mikhail A Chetvertkov, et al.
Medical Physics|July 28, 2007
Design of respiration averaged CT for attenuation correction of the PET data from PET/CTPai-Chun Melinda Chi, Osama Mawlawi, Sadek A Nehmeh, et al.
Medical Physics|September 2, 2017
An FMEA evaluation of intensity modulated radiation therapy dose delivery failures at tolerance criteria levelsJacqueline Tonigan Faught, Peter A Balter, Jennifer L Johnson, et al.
Journal of Applied Clinical Medical Physics|March 15, 2017
Reproducibility of patient setup in the seated treatment position: A novel treatment chair designRachel E McCarroll, Beth M Beadle, Danna Fullen, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|August 11, 2014
Stereotactic ablative radiotherapy (SABR) using 70 Gy in 10 fractions for non-small cell lung cancer: exploration of clinical indicationsQiaoqiao Li, Cameron W Swanick, Pamela K Allen, et al.
Pageof 8